Virax Biolabs Group Stock Forecast

Sell candidate since Jul 10, 2026 Loss -4.66%

The Virax Biolabs Group Limited stock price gained 2.64% on the last trading day (Monday, 20th Jul 2026), rising from $3.79 to $3.89. During the last trading day the stock fluctuated 14.17% from a day low at $3.60 to a day high of $4.11. The price has fallen in 6 of the last 10 days but is still up by 25.08% over the past 2 weeks. Volume fell on the last day by -92 thousand shares and in total, 311 thousand shares were bought and sold for approximately $1.21 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.49% during the next 3 months and, with a 90% probability hold a price between $2.59 and $7.52 at the end of this 3-month period.

VRAX Signals & Forecast

There are mixed signals in the stock today. The Virax Biolabs Group Limited stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $4.10. On a fall, the stock will find some support from the short-term average at $3.85. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, May 20, 2026, and so far it has fallen -51.22%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Virax Biolabs Group Limited stock

Virax Biolabs Group Limited finds support from accumulated volume at $3.73 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.510 between high and low, or 14.17%. For the last week the stock has had daily average volatility of 14.16%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (VRAX) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Virax Biolabs Group Limited to open at $3.87, and during the day (based on 14 day Average True Range), to move between $3.34 and $4.44, which gives a possible trading interval of +/-$1.10 (+/-32.85%) up or down from last closing price. If Virax Biolabs Group Limited takes out the full calculated possible swing range there will be an estimated 32.85% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.90 (0.26%) than the support at $3.73 (4.18%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Virax Biolabs Group Limited stock A Buy?

Virax Biolabs Group Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.915 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 21, 2026 - $3.87 ( 0.600%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk